This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Dong Wha Pharmaceutical Ind. Co., Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Hwan Bong Chang: Innovator in Pharmaceutical Chemistry
Introduction
Hwan Bong Chang is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods in drug preparation. His work is characterized by a commitment to improving existing processes and enhancing the efficacy of pharmaceutical compounds.
Latest Patents
Hwan Bong Chang holds a patent for a process titled "Process for preparing N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)-phenoxy]-pentoxy}-benzamidine." This invention relates to an improved method of preparing N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine. His innovative approach aims to streamline the preparation process, making it more efficient and effective.
Career Highlights
Hwan Bong Chang is currently associated with Dong Wha Pharmaceutical Ind. Co., Ltd. His role in the company allows him to apply his expertise in pharmaceutical development and contribute to the advancement of drug formulations. His dedication to research and development has positioned him as a valuable asset in the industry.
Collaborations
Hwan Bong Chang has collaborated with notable colleagues, including Jin Soo Lee and Seok Hoon Ahn. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.
Conclusion
Hwan Bong Chang's contributions to pharmaceutical chemistry through his innovative patent and collaborative efforts highlight his importance in the field. His work continues to influence the development of effective pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile